Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 9
Submit an article Journal homepage
668
Views
1
CrossRef citations to date
0
Altmetric
Commentaries

Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responses

Christine M. MinnarDepartment of Dermatology, School of Medicine, University of California, Davis, Sacramento, CA, USA
&
William J. MurphyDepartment of Dermatology, School of Medicine, University of California, Davis, Sacramento, CA, USA;Department of Internal Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USACorrespondence[email protected]
Pages 2249-2252 | Received 16 Mar 2016, Accepted 30 Mar 2016, Published online: 13 Jul 2016

References

  • Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK and Mescher MF. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. JI 1999; 162:3256-62
  • Yamamoto T, Hattori M, and Yoshida T. Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell. Immunology 2007; 121:383-91; PMID:17376194; http://dx.doi.org/10.1111/j.1365-2567.2007.02586.x
  • Schwartz RH. T cell anergy: is there a common molecular mechanism? JEM 1996; 184(1):1-8; http://dx.doi.org/10.1084/jem.184.1.1
  • Bitegye C, Hannier S, Guérif S, Valitutti S, Demotz S. Tuning of T Cell clone size and activation threshold by control of CD25 expression through mitogen-activated protein kinase pathways. Int Arch Allergy and Immunol 2002; 127:322-32; http://dx.doi.org/10.1159/000057750
  • Acuto O and Frederique M. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003; 3:939-51; PMID:14647476; http://dx.doi.org/10.1038/nri1248
  • Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DEC, Alderson KA, Sungur CM, Ames E, Mirsoian A, et al. Out-of-Sequence signal 3 paralyzes primary CD4+T-cell-dependent immunity. Immunity 2015; 43:240-50; PMID:26231116; http://dx.doi.org/10.1016/j.immuni.2015.06.023
  • Urban SL, Welsh RM. Out-of-Sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses. PLoS Pathogens 2014; 10:e1004357; PMID:25255454; http://dx.doi.org/10.1371/journal.ppat.1004357
  • Schwartz RH. T cell anergy. Annu Rev Immunol 2003; 21:305-34; PMID:12471050; http://dx.doi.org/10.1146/annurev.immunol.21.120601.141110
  • Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. JEM 2001; 194:1711-9; http://dx.doi.org/10.1084/jem.194.12.1711
  • Berard M and Tough DF. Qualitative differences between naïve and memory T cells. Immunology 2002; 106:127-38; PMID:12047742; http://dx.doi.org/10.1046/j.1365-2567.2002.01447.x
  • Tietze JK, Wilkins DEC, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, et al. Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy. Blood 2012; 119:3073-83; PMID:22251483; http://dx.doi.org/10.1182/blood-2011-07-369736
  • Ehl S, Hombach J, Aichele P, Hengartner H and Zinkernagel RM. Bystander activation of cytotoxic T cells: Studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. JEM 1997; 185:1241-51; http://dx.doi.org/10.1084/jem.185.7.1241
  • Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, et al. Bystander activation and anti-tumor effects of CD8+ T cells following interleukin-2 based immunotherapy is independent of CD4+ T cell help. PLoS ONE 2014; 9:e102709; PMID:25119341; http://dx.doi.org/10.1371/journal.pone.0102709
  • Berner V, Liu H, Zhou Q, Alderson KL, Sun K, Weiss JM, Back TC, Longo DL, Blazar BR, Wiltrout RH, et al. IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat Med 2007; 13:354-60; PMID:17334371; http://dx.doi.org/10.1038/nm1554
  • Palmer DC and Restifo NP. Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function. Trends Immunol 2009; 30:592-602; PMID:19879803; http://dx.doi.org/10.1016/j.it.2009.09.009

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.